quinazolines has been researched along with HMN (Hereditary Motor Neuropathy) Proximal Type I in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andresson, T; Bedell, L; Bjornsson, JM; Bragason, G; Burghes, AH; Butchbach, ME; Coovert, DD; Gurney, ME; Haraldsson, M; Keyvan, M; Mishra, R; Pai, G; Palomo, M; Pease, B; Rao, M; Singh, J; Thosteinsdottir, M; Thurmond, J | 1 |
1 other study(ies) available for quinazolines and HMN (Hereditary Motor Neuropathy) Proximal Type I
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Topics: Aminoquinolines; Animals; Biological Availability; Blood-Brain Barrier; Cell Line; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Fibroblasts; Folic Acid Antagonists; Heterozygote; Humans; Mice; Models, Molecular; Molecular Conformation; Muscular Atrophy, Spinal; Nerve Tissue Proteins; Permeability; Piperidines; Promoter Regions, Genetic; Quinazolines; RNA-Binding Proteins; SMN Complex Proteins; Spinal Muscular Atrophies of Childhood; Stereoisomerism; Structure-Activity Relationship; Survival of Motor Neuron 1 Protein; Survival of Motor Neuron 2 Protein; Tetrahydrofolate Dehydrogenase | 2008 |